Key facts
- This page summarizes Sam Eldessouky's Form 4 filing for Bausch Health Companies Inc. (BHC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jun 2021, 17:26.
Sam Eldessouky - 01 Jun 2021 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- BHC
- Reported as of
- 01 Jun 2021
- Net transaction value
- +$3,921,337
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2021, 17:26:21 UTC
- Next SEC filing
- 15 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kirsten O'Donnell, attorney-in-fact for Sam Eldessouky
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sam Eldessouky filed Form 4 for Bausch Health Companies Inc. (BHC) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$3,921,337.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BHC
transaction
Common Shares, No Par Value
Award
- Transaction value
- $0
- Shares
- +33,673
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 133,857
- Date
- 01 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BHC
transaction
Derivative
Non-Qualified Stock Options (right to purchase)
Award
- Transaction value
- $3,921,337
- Shares
- +122,427
- Change %
- Price
- $32.03
- Shares after
- 122,427
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Shares, No Par Value
- Underlying amount
- 122,427
- Exercise price
- $32.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer
Footnote F2
The options vest in equal installments on each of the first three anniversaries of the date of grant.